Morbidities and Mortality in Transfusion-Dependent Beta-Thalassemia Patients (Single-Center Experience)

Abstract

In the past 10 years, the survival and morbidity rates in our center have markedly improved as a result of regular blood transfusion, new iron chelators, and better compliance of the patients.